Clinical impact of high serum hepatocyte growth factor in advanced non-small cell lung cancer.
Tsuji T, Sakamori Y, Ozasa H, Yagi Y, Ajimizu H, Yasuda Y, Funazo T, Nomizo T, Yoshida H, Nagai H, Maeno K, Oguri T, Hirai T, Kim YH.
Tsuji T, et al.
Oncotarget. 2017 May 16;8(42):71805-71816. doi: 10.18632/oncotarget.17895. eCollection 2017 Sep 22.
Oncotarget. 2017.
PMID: 29069748
Free PMC article.